Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 24.94
-0.598 %
$ 699 M
Market Cap
118.76
P/E
Price Target
Average
58.38%
Revenue Forecast
Estimate
18.68%
EBIT
Estimate
--8.09%
Net Income
Estimate
55.81%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Castle Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for CSTL of $39.5 , with forecasts ranging from
a
low of
$35 to a high of $45 .
CSTL Lowest Price Target
Wall Street Target
35 USD
40.34%
CSTL Average Price Target
Wall Street Target
39.5 USD
58.38%
CSTL Highest Price Target
Wall Street Target
45 USD
80.43%
REVENUE FORECAST
Revenue Forecast Chart CSTL
EBIT FORECAST
EBIT Forecast Chart CSTL
NET INCOME FORECAST
Net Income Chart CSTL